jump to content jump to footer

Potential of using structured data from clinical trials and routine for AI and radiomics research

Dr. Nils Grosse Hokamp shares his experience of using mint Lesion™ at the University Hospital Cologne in this brief interview. He talks about how they have expanded their usage of mint Lesion™ over the years, how it has changed their clinical studies, and his view on the potential of structured data for research.

Video Clinical Trials Standardized Reading Procedures Clinical Routine Therapy Response Assessment AI Radiomics Structured Reporting

Related Resources

Radiologists participating in a hands-on lung cancer screening workshop using structured reporting software mint Lesion at RÖKO 2026
Interactive hands-on workshop on lung cancer screening according to G-BA guidelines at RÖKO 2026, including structured reporting, double reading workflows, and consensus decision-making
Hands-On Workshop Lung Cancer Screening: From Initial Read to Consenus
From initial read to consensus – structured reporting in practice at RÖKO 2026
Radiologist analyzing whole-body MRI scans of multiple myeloma using AI-assisted quantification in mint Lesion
How mint Lesion supports radiologists in AI-assisted quantification of bone involvement in multiple myeloma with structured analysis, objective metrics, and longitudinal disease tracking.
AI-Supported Quantification of Bone Involvement in Multiple Myeloma
Radiologists utilize Whole-Body MRI (WB-MRI) as an established imaging method for multiple myeloma staging [1,3]. Because it avoids ionizing…
Radiologist using mint Lesion for structured lung cancer screening reporting and AI-assisted lung nodule assessment
How mint Lesion supports radiologists in the German lung cancer screening program through structured reporting, AI-supported workflows, second reading, and longitudinal patient follow-up.
Lung Cancer Screening in Germany: How mint Lesion Supports Radiologists in Clinical Practice
A New Era of Early Detection — and New Challenges With the introduction of the nationwide lung cancer screening program starting in 2026,…